Philippe Boucheron - Deputy Director of Life Sciences, Bpifrance
Between 1993 and 1996, Philippe Boucheron worked as an associate at BioCapital LP, one of the largest Canadian venture capital funds focusing on healthcare. From 1997 to 2000, he directed the mid-caps equity research team at ING Barings Ferri, Paris. Here, he spent a significant part of his time following French and European listed biotech companies. In 2000, he co-founded the Bioam Funds dedicated to early-stage life science investments and became Investment Manager, then in 2004 Managing Partner. After the merger of Bioam with CDC entreprises in July 2010, Philippe Boucheron joined the CDC Entreprises life sciences' team as Investment Manager. In 2013, CDC Entreprises, FSI and Oséo merged to create Bpifrance. Since, he is deputy chief of the Life Investments BU and sits on Bpifrance Investissement's Investment Committee. Philippe Boucheron also sits on the boards of Ademtech, Integragen, SSI, Advicenne, ART, GamaMabs and CorWave. Philippe Boucheron holds an engineering degree in Biochemical Engineering and Microbial genetics from the Institut National des Sciences Appliquées in Toulouse, a MSc in Biochemical Engineering from the Ecole Polytechnique of Montreal, and a MBA from INSEAD.